Clare Nasmyth‐Miller

657 total citations
11 papers, 501 citations indexed

About

Clare Nasmyth‐Miller is a scholar working on Pediatrics, Perinatology and Child Health, Epidemiology and Transplantation. According to data from OpenAlex, Clare Nasmyth‐Miller has authored 11 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 5 papers in Epidemiology and 5 papers in Transplantation. Recurrent topics in Clare Nasmyth‐Miller's work include Renal Transplantation Outcomes and Treatments (5 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Influenza Virus Research Studies (3 papers). Clare Nasmyth‐Miller is often cited by papers focused on Renal Transplantation Outcomes and Treatments (5 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Influenza Virus Research Studies (3 papers). Clare Nasmyth‐Miller collaborates with scholars based in United Kingdom, United States and Switzerland. Clare Nasmyth‐Miller's co-authors include Flavio Vincenti, Henrik Ekberg, Josep M. Grinyó, Matthew Truman, Björn Nashan, Athina Voulgari, Michelle Rashford, Yves Vanrenterghem, Ewa Olech and S. Radominski and has published in prestigious journals such as Hepatology, Transplantation and American Journal of Transplantation.

In The Last Decade

Clare Nasmyth‐Miller

11 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clare Nasmyth‐Miller United Kingdom 7 285 127 118 109 85 11 501
A. McLean United Kingdom 10 318 1.1× 139 1.1× 80 0.7× 51 0.5× 70 0.8× 16 508
C F Barker United States 9 406 1.4× 342 2.7× 44 0.4× 122 1.1× 149 1.8× 19 729
V.R. Peddi United States 13 363 1.3× 208 1.6× 26 0.2× 103 0.9× 82 1.0× 33 546
Fernando Cosio United States 6 523 1.8× 290 2.3× 15 0.1× 84 0.8× 95 1.1× 14 646
Janka Slatinská Czechia 10 234 0.8× 105 0.8× 31 0.3× 75 0.7× 22 0.3× 38 369
Hideari Ihara Japan 10 141 0.5× 152 1.2× 30 0.3× 45 0.4× 39 0.5× 46 453
Manel Perelló Spain 13 323 1.1× 164 1.3× 14 0.1× 106 1.0× 35 0.4× 31 547
Adele Rike United States 7 629 2.2× 341 2.7× 16 0.1× 95 0.9× 54 0.6× 11 761
Andrew Bentall United States 14 491 1.7× 285 2.2× 15 0.1× 68 0.6× 48 0.6× 51 693
Delphine Morel France 11 97 0.3× 97 0.8× 29 0.2× 33 0.3× 26 0.3× 18 368

Countries citing papers authored by Clare Nasmyth‐Miller

Since Specialization
Citations

This map shows the geographic impact of Clare Nasmyth‐Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clare Nasmyth‐Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clare Nasmyth‐Miller more than expected).

Fields of papers citing papers by Clare Nasmyth‐Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clare Nasmyth‐Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clare Nasmyth‐Miller. The network helps show where Clare Nasmyth‐Miller may publish in the future.

Co-authorship network of co-authors of Clare Nasmyth‐Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Clare Nasmyth‐Miller. A scholar is included among the top collaborators of Clare Nasmyth‐Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clare Nasmyth‐Miller. Clare Nasmyth‐Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Gibiansky, Leonid, Annabelle Lemenuel‐Diot, Patanjali Ravva, et al.. (2021). Dosing regimen optimisation for oseltamivir in immunocompromised paediatric patients with influenza: Extrapolation of efficacy. British Journal of Clinical Pharmacology. 88(3). 1189–1201. 1 indexed citations
2.
Lemenuel‐Diot, Annabelle, Kashyap Patel, Leonid Gibiansky, et al.. (2020). Pharmacologic effects of oseltamivir in immunocompromised adult patients as assessed by population PK/PD analysis and drug‐disease modelling for dosing regimen optimization. British Journal of Clinical Pharmacology. 87(3). 1359–1368. 3 indexed citations
3.
Bautista, Francisco, Dan Engelhard, Carmelo Rizzari, et al.. (2019). Pharmacokinetics and Pharmacodynamics of Conventional-Dose vs Triple-Dose Oseltamivir in Severely Immunocompromised Children With Influenza. Open Forum Infectious Diseases. 6(10). ofz430–ofz430. 4 indexed citations
4.
Wirth, Stefan, Hongfei Zhang, Winita Hardikar, et al.. (2018). Efficacy and Safety of Peginterferon Alfa‐2a (40KD) in Children With Chronic Hepatitis B: The PEG‐B‐ACTIVE Study. Hepatology. 68(5). 1681–1694. 35 indexed citations
5.
Kivitz, Alan, Ewa Olech, Michael Borofsky, et al.. (2017). Two-year Efficacy and Safety of Subcutaneous Tocilizumab in Combination with Disease-modifying Antirheumatic Drugs Including Escalation to Weekly Dosing in Rheumatoid Arthritis. The Journal of Rheumatology. 45(4). 456–464. 15 indexed citations
6.
Kivitz, Alan, Ewa Olech, Michael Borofsky, et al.. (2014). Subcutaneous Tocilizumab Versus Placebo in Combination With Disease‐Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis. Arthritis Care & Research. 66(11). 1653–1661. 120 indexed citations
7.
Ekberg, Henrik, Josep M. Grinyó, Björn Nashan, et al.. (2008). Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients. Clinical Journal of the American Society of Nephrology. 3(1). 7–9. 1 indexed citations
8.
Grinyó, Josep M., Yves Vanrenterghem, Björn Nashan, et al.. (2008). Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transplant International. 21(9). 879–891. 94 indexed citations
9.
Ekberg, Henrik, Josep M. Grinyó, Björn Nashan, et al.. (2007). Cyclosporine Sparing with Mycophenolate Mofetil, Daclizumab and Corticosteroids in Renal Allograft Recipients: The CAESAR Study. American Journal of Transplantation. 7(3). 560–570. 216 indexed citations
10.
Vincenti, Flavio, Yves Vanrenterghem, Björn Nashan, et al.. (2005). The use of mycophenolate mofetil, daclizumab and corticosteroids with cyclosporine (low dose, low dose/withdrawal and standard dose) to optimize renal function in renal allograft recipients - 18 month results. American Journal of Transplantation. 5. 539–540. 6 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. McLean Breakdown of academic impact, for papers by C F Barker Breakdown of academic impact, for papers by V.R. Peddi Breakdown of academic impact, for papers by Fernando Cosio Breakdown of academic impact, for papers by Janka Slatinská Breakdown of academic impact, for papers by Hideari Ihara Breakdown of academic impact, for papers by Manel Perelló Breakdown of academic impact, for papers by Adele Rike Breakdown of academic impact, for papers by Andrew Bentall Breakdown of academic impact, for papers by Delphine Morel
Rankless by CCL
2026